Focus Feature:
Quality improvement program reduces blood pressure control disparities
A Kaiser Permanente Southern California quality improvement program, which harnessed clinical and culturally responsive care strategies, nearly halved the racial disparities previously seen in blood pressure control between Black and white adults.
R&E News and Features
Immunocompromised people not getting recommended COVID shots
A study of more than 40,000 immunocompromised people showed that, by early August 2022, only 1% had received 5 doses of mRNA COVID-19 vaccines as was recommended by the Centers for Disease Control and Prevention at the time.
Original COVID-19 vaccine booster effect wanes against BA.4 and BA.5
The protection provided by third and fourth doses of the monovalent Moderna COVID-19 vaccine against infection with omicron subvariants wanes after 3 months, but protection against hospitalization remains high.
In the News
Only 1% of immune-impaired U.S. adults have gotten the recommended 5 COVID vaccine doses
Center for Infectious Disease Research and PolicyJanuary 24, 2023Physical activity linked to lower all-cause mortality risk among breast cancer survivors
HealioJanuary 17, 2023Quality improvement program narrows systemwide racial disparities in BP control
HealioJanuary 6, 2023Ditch the multivitamins and take a cold shower: New Year wellness resolutions for 2023
USA TodayJanuary 5, 2023
Five questions...
for Dr. Hung Fu Tseng
In this Q&A, Dr. Hung Fu Tseng, a senior scientist in the Department of Research & Evaluation, discusses his life and his research, which focuses on generating real-world evidence to determine the safety and effectiveness of vaccines.